ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 242 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $966 | +8.2% | 73,490 | +3.7% | 0.01% | 0.0% |
| Q2 2023 | $893 | -7.3% | 70,851 | -4.0% | 0.01% | 0.0% |
| Q1 2023 | $963 | -26.1% | 73,778 | -0.2% | 0.01% | -40.0% |
| Q4 2022 | $1,303 | -99.9% | 73,889 | -4.8% | 0.01% | +11.1% |
| Q3 2022 | $1,182,000 | +280.1% | 77,583 | +270.0% | 0.01% | +350.0% |
| Q2 2022 | $311,000 | -45.1% | 20,967 | -16.7% | 0.00% | -33.3% |
| Q1 2022 | $567,000 | +27.1% | 25,158 | +4.0% | 0.00% | +50.0% |
| Q4 2021 | $446,000 | +48.2% | 24,181 | +7.5% | 0.00% | 0.0% |
| Q3 2021 | $301,000 | -23.8% | 22,491 | +5.5% | 0.00% | 0.0% |
| Q2 2021 | $395,000 | +44.2% | 21,328 | +17.0% | 0.00% | 0.0% |
| Q1 2021 | $274,000 | +27.4% | 18,234 | +22.4% | 0.00% | +100.0% |
| Q4 2020 | $215,000 | -27.9% | 14,896 | -28.9% | 0.00% | -50.0% |
| Q3 2018 | $298,000 | -32.3% | 20,941 | -42.9% | 0.00% | -33.3% |
| Q2 2018 | $440,000 | -6.2% | 36,660 | -3.5% | 0.00% | 0.0% |
| Q1 2018 | $469,000 | -44.4% | 37,997 | -34.4% | 0.00% | -50.0% |
| Q4 2017 | $843,000 | +315.3% | 57,933 | +306.5% | 0.01% | +500.0% |
| Q3 2017 | $203,000 | +16.0% | 14,252 | +3.9% | 0.00% | 0.0% |
| Q2 2017 | $175,000 | -2.2% | 13,716 | -2.7% | 0.00% | 0.0% |
| Q1 2017 | $179,000 | +24.3% | 14,100 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $144,000 | -42.6% | 14,100 | -26.0% | 0.00% | -50.0% |
| Q3 2016 | $251,000 | -21.3% | 19,058 | -24.2% | 0.00% | 0.0% |
| Q2 2016 | $319,000 | +9.2% | 25,127 | +13.8% | 0.00% | 0.0% |
| Q1 2016 | $292,000 | +14.5% | 22,086 | +33.0% | 0.00% | 0.0% |
| Q4 2015 | $255,000 | -2.3% | 16,609 | -21.2% | 0.00% | 0.0% |
| Q3 2015 | $261,000 | +186.8% | 21,069 | +217.6% | 0.00% | +100.0% |
| Q2 2015 | $91,000 | +46.8% | 6,634 | +27.8% | 0.00% | – |
| Q1 2015 | $62,000 | -6.1% | 5,190 | +0.6% | 0.00% | -100.0% |
| Q4 2014 | $66,000 | -20.5% | 5,161 | -16.1% | 0.00% | 0.0% |
| Q3 2014 | $83,000 | -16.2% | 6,155 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $99,000 | -6.6% | 6,155 | +4.3% | 0.00% | 0.0% |
| Q1 2014 | $106,000 | +15.2% | 5,902 | -1.3% | 0.00% | 0.0% |
| Q4 2013 | $92,000 | -71.1% | 5,982 | -72.0% | 0.00% | -66.7% |
| Q3 2013 | $318,000 | +132.1% | 21,363 | +102.4% | 0.00% | +200.0% |
| Q2 2013 | $137,000 | – | 10,557 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |